CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a top employer in the global biopharmaceutical industry in Science and Science Careers ...

Fintel reports that on October 23, 2025, UBS maintained coverage of Moderna (NasdaqGS:MRNA) with a Buy recommendation.

CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event – Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025. The ...

Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing Phase 2 trial in bone marrow transplant patients Company does not anticipate ...

Mixed options sentiment in Moderna (MRNA), with shares up 33c, or 1.26%, near $26.58. Options volume running well above average with 93k contracts ...

The findings revealed that the molecule that powers those specific vaccines, mRNA, has been shown to help the immune system ...

A bipartisan group of senators is working to draft legislation to reform a fast-growing hospital drug discount program designed to help low-income patients.

COVID-19 vaccines may enhance immune responses in some cancer patients, improving tumor treatment outcomes, according to new ...

Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...

Minnesota is seeing a surge in bird flu cases, with nearly 600,000 birds affected this fall as migrating wild birds spread ...

Today’s ACT Brief explores how eConsent is modernizing participant engagement, highlights new data on global representation in breast cancer trials, and examines Moderna’s decision to halt its Phase ...

STATEN ISLAND, NEW YORK / ACCESS Newswire / October 23, 2025 / CMG Home Loans, the retail division of well-capitalized privately held mortgage lender, CMG Financial, is pleased to announce the ...